An article by our collaborator Irene Tarragó

How incredible!, it’s 2020! For a person who, like me, was born in 1958, this year sounds like science fiction. But well, things have been developing, advances have been made and, for now, reality has not yet advanced fiction. We still don’t have flying cars or android-like taxi drivers and we have not achieved teleportation, which is what I would like the most. No pollution, no traffic jams, nothing. You would think where you want to go and there you go by magic. It would be wonderful.

And as usual, at this time, I wish you the best for this year, and that the discoveries, advances or devices to treat epilepsy, to prevent their seizures, have development they lack. We are in 2020, there are diseases that are still a little under-researched in terms of progress. I tell you that, apart from epilepsy, I also have hemochromatosis, whose only treatment is to periodically transfuse blood. Those transfusions extract between 300 or 400mg of blood, every time you go. In my case, about 6 times a year. It’s horrifying. The veins are weakened from so many perforations (the needles are rather big). And I can’t understand that, in the 21st century, this is still so undeveloped.

We are in 2020, there are diseases that are still a little under-researched in terms of progress

So, from all fields, we have to give a boost to medical research and everything surrounding it. In the small political reach that I can cover now, I will promote research into diseases whose treatments have become more obsolete and the bureaucratic and administrative facilitation of the procedures that many devices have to go through until they reach the market.

May you all have a great year.

Leave a Reply

Open chat
Contact with us now
Chat with Anna
¡Hola! 👋🏻
Soy Anna, ¿en qué puedo ayudarte?

The user who fills in the information requested in this form declares to be entitled to do so and is solely responsible for the accuracy and completeness of the data and information entered, expressly exonerating MJN NEUROSERVEIS of any liability that may arise for this entity on the occasion of the information provided through this form.

Yes, I accept

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!

    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.


      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.